Clinical and pathological comparison of proximal and distal colorectal adenocarcinoma
DOI:
https://doi.org/10.5281/zenodo.1004587Keywords:
Colorectal neoplasms, surgery, humanAbstract
AIM: Colorectal cancer is a major cause of morbidity and mortality worldwide. Recent studies suggest that proximal and distal colorectal cancers may represent different forms of the disease. The purpose of this study was to evaluate demographic, clinical and pathologic characteristics of colorectal cancer regarding the distribution within the colon and rectum.
METHODS: One hundred fifty-five consecutive patients with primary colorectal carcinoma were analyzed. Proximal (up to the splenic flexure) and distal (splenic flexure to the rectum) colorectal cancers were compared regarding age, gender, stage, differentiation, mucinous content and the presence of distant metastases and peritoneal carcinosis.
RESULTS: No significant difference in age and gender was observed between proximal and distal tumors. Proximal tumors were not significantly more advanced at the time of diagnosis compared to distal tumors according to tumor size, Dukes and Astler-Coller classification. However, proximal tumors had significantly higher frequency of pT4 stage, liver metastases, peritoneal carcinosis and poor differentiation. Mucinous carcinomas were found more often in the proximal colon, but not significantly.
CONCLUSION: These results support the hypothesis that proximal and distal colorectal cancers may have different biological behavior. Further large studies should be performed to evaluate the clinical significance of differences found in this study, and possible impact on screening, diagnosis, therapy and survival.
References
2. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer. 1999;85(8):1670-1676.
3. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA. 2000;284(8):1008-1015.
4. Midgley R, Kerr D. Colorectal cancer. Lancet. 1999;353(9150):391-399.
5. Bonithon-Kopp C, Benhamiche AM. Are there several colorectal cancers? Epidemiological data. Eur J Cancer Prev. 1999;8 Suppl 1:S3-12.
6. Miller A, Gorska M, Bassett M. Proximal shift of colorectal cancer in the Australian Capital Territory over 20 years. Aust N Z J Med. 2000;30(2):221-225.
7. Demers RY, Severson RK, Schottenfeld D, Lazar L. Incidence of colorectal adenocarcinoma by anatomic subsite. An epidemiologic study of time trends and racial differences in the Detroit, Michigan area. Cancer. 1997;79(3):441-447.
8. Ji BT, Devesa SS, Chow WH, Jin F, Gao YT. Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol Biomarkers Prev. 1998;7(8):661-666.
9. Franceschi S, La Vecchia C. Colorectal cancer and hormone replacement therapy: an unexpected finding. Eur J Cancer Prev. 1998;7(6):427-438.
10. Yoo KY, Tajima K, Inoue M, Takezaki T, Hirose K, Hamajima N, Park SK, Kang DH, Kato T, Hirai T. Reproductive factors related to the risk of colorectal cancer by subsite: a case-control analysis. Br J Cancer. 1999;79(11-12):1901-1906.
11. Chao A, Gilliland F, Willman C, Joste N, Chen IM, Stone N, Ruschulte J, Viswanatha D, Duncan P, Ming R, Hoffman R, Foucar E, Key C. Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study. Cancer Epidemiol Biomarkers Prev. 2000;9(6):539-544.
12. Diez M, Medrano M, Muguerza JM, Ramos P, Hernandez P, Villeta R, Martin A, Noguerales F, Ruiz A, Granell J. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas. Anticancer Res. 2000;20(5C):3907-3912.
13. Gervaz P, Bouzourene H, Cerottini JP, Chaubert P, Benhattar J, Secic M, Wexner S, Givel JC, Belin B. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum. 2001;44(3):364-372; discussion 372-363.
14. Auvinen A, Isola J, Visakorpi T, Koivula T, Virtanen S, Hakama M. Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer. 1994;70(2):293-296.
15. Ikeda Y, Koyanagi N, Mori M, Minagawa S, Toyomasu T, Ezaki T, Tateishi H, Sugimachi K. Tumor stage in the proximal colon under conditions of a proximal shift of colorectal cancer with age. Hepatogastroenterology. 1998;45(23):1535-1538.
16. Loffeld R, Putten A, Balk A. Changes in the localization of colorectal cancer: implications for clinical practice. J Gastroenterol Hepatol. 1996;11(1):47-50.
17. Saltzstein SL, Behling CA, Savides TJ. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer. 1998;82(7):1408-1410.
18. Ikeda Y, Mori M, Koyanagi N, Minagawa S, Kondo N, Fujimaru R, Kojima Y, Kondo A, Sugimachi K. Possibility of different cancer development between the proximal and distal colon: comparison of the distribution between adenomatous polyps and cancer. Hepatogastroenterology. 1998;45(23):1583-1586.
19. Jernvall P, Makinen M, Karttunen T, Makela J, Vihko P. Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers. Int J Cancer. 1997;74(1):97-101.
20. Yamamoto S, Mochizuki H, Hase K, Yamamoto T, Ohkusa Y, Yokoyama S, Ushitani Y, Tamakuma S. Assessment of clinicopathologic features of colorectal mucinous adenocarcinoma. Am J Surg. 1993;166(3):257-261.
Downloads
Published
How to Cite
Issue
Section
License
Articles in BioMedicine and Surgery are published under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license. Full text of Attribution-NonCommercial-NoDerivatives 4.0 International license can be viewed at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.
